Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
Many individuals with schizophrenia also suffer from marijuana addiction. Clozapine, an
atypical antipsychotic medication, may prove useful at preventing drug relapse in
schizophrenic individuals who are seeking treatment for marijuana addiction. The purpose of
this study is to compare the effectiveness of clozapine, vs. treatment-as-usual with other
oral antipsychotics at reducing marijuana use in schizophrenic individuals.
Phase:
Phase 4
Details
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Collaborators:
National Institute on Drug Abuse (NIDA) University of Missouri, Kansas City University of South Carolina VA Medical Center-West Los Angeles